WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the Biotech Showcase Conference on Tuesday, January 12, 2010 at 11:40 am PT, at the Marines’ Memorial Club & Hotel in San Francisco.
